Forest Sues To Keep Generic Lexapro Off Market

Law360, New York (July 11, 2006, 12:00 AM EDT) -- Forest Laboratories Inc. and its Danish licensing partner H. Lundbeck A/S have filed their third separate lawsuit to stop a generic version of the blockbuster antidepressant drug Lexapro from entering the market.

In its complaint filed Monday in the U.S. District Court in Detroit, Forest accused Caraco Pharmaceutical Laboratories Ltd. of infringing its patent when it applied to the Food and Drug Administration for approval to sell a generic version of Lexapro.

Though the FDA has not decided whether to approve the request, Forest argued that...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.